This infographic illustrates the key achievements of the project to establish and validate a manufacturing process to produce semisynthetic artemisinin (ssART) at industrial scale and commercialize ssART. Production of ssART aims to supplement a historically volatile botanical supply chain, strengthening the artemisinin market and ensuring that the global need for artemisinin-based combination therapies can be met, thus supporting current worldwide malaria control measures and strategies for malaria elimination.